Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolic ...

A breath test device that detects what can be an utterly debilitating but treatable condition has been bought by Rosemere ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.